Background Phosphorylated tau (p-tau) epitopes in cerebrospinal fluid (CSF) are accurate
biomarkers for a pathological and clinical diagnosis of Alzheimer's disease (AD) and are seen …

… studies have investigated the cerebrospinal fluid (CSF) in … There are few reports on results
from CSF analysis in patients … -19, but rather to select patients with whom we had optimal …

… taken for nanoparticle tracking analysis (NTA) and flow cytometry analysis. To prepare the
… in 40 μL of PBS, rapidly frozen in liquid nitrogen, aliquoted and stored at -80C until analysis. …

… content itself, we performed a proteomics analysis of CSF sampled from PBM-depleted …
analysis was conducted, and an elbow plot was used to select the first 30 PCs for tSNE analysis …

… In conclusion, the correlation analysis and QC pipelines … event we employed surrogate
variable analysis (SVA) to perform … of any particular phenotype-specific analyses, we generated a …

… analysis was performed using the Chi-squared and Fisher’s exact tests, as appropriate. A
logistic regression model was constructed for multivariate analysis… On multivariate analysis, a …

… We decided to use all of the available data for further analysis by combining all patients in
one … The 100 voxel extent threshold was chosen and finally we used xjview (45) toolbox for …

It remains unclear how immune cells from skull bone marrow niches are recruited to the
meninges. Here we report that cerebrospinal fluid (CSF) accesses skull bone marrow via dura–…

… Fungal clearance from cerebrospinal fluid was −0.40 log 10 colony-forming units (CFU)
per milliliter per day in the liposomal amphotericin B group and −0.42 log 10 CFU per milliliter …

… -analysis demonstrated that GFAP levels were consistently altered in the cerebrospinal fluid
… Our results point to plasma GFAP as a possible biomarker specific for Aβ pathology. First, …